MANGALAM — Mangalam Drugs and Organics Cashflow Statement
0.000.00%
- IN₹734.27m
- IN₹1.55bn
- IN₹3.18bn
- 47
- 92
- 17
- 52
Annual cashflow statement for Mangalam Drugs and Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 395 | 277 | 22.1 | -111 | 47.9 |
| Depreciation | |||||
| Non-Cash Items | 80.6 | 121 | 129 | 132 | 140 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -292 | -244 | 134 | -45.9 | 72.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 275 | 257 | 395 | 122 | 426 |
| Capital Expenditures | -314 | -277 | -279 | -179 | -202 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.51 | 3.43 | 57.4 | 0.112 | 7.29 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -313 | -273 | -222 | -179 | -195 |
| Financing Cash Flow Items | -93.3 | -112 | -128 | -139 | -149 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27 | 29.8 | -166 | 57 | -217 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.4 | 13.6 | 7.34 | -0.373 | 14.1 |